Market Overview
The instruments used in medical industry require proper cleaning and disinfection in order to prevent any possibility of infection arising as a result of foreign particles and pathogens. The global instrument infection control market is estimated to obtain a CAGR of 6.38% during the forecast period, i.e., 2020-2027. The market attained a value of USD 4,275.00 million in the year 2018 and is further anticipated to reach USD 7,408.72 million by the end of 2027. The market for instrument infection control is predicted to witness a substantial growth on account of rising prevalence of infections due to impure surgical and other medical instruments.
Growth Highlights based on Region during 2018-2027
The global instrument infection control market is segmented by regions into North America, Latin America, Europe, Asia-Pacific and Middle East and Africa, out of which, the market in North America is anticipated to hold a significant share by 2027 on account of growing investments from private and government institutions in the healthcare industry. The instrument infection control market in the U.S. is anticipated to grow with a CAGR of 6.61% over the forecast period, mainly on the back of development of innovative infection control products in the region. The highest growth rate during the forecast period is predicted to be observed by the market in Asia Pacific. This can be attributed to the rising awareness in the region about regular disinfection of medical instruments so as to avoid risk of infections. In Asia Pacific, countries such as China and India are anticipated to impact the market growth the most in the upcoming years. CLICK TO DOWNLOAD SAMPLE REPORT
Market Segmentation Synopsis
By Product
On the basis of product, the global instrument infection control market is segmented into cleaning, disinfection and sterilization. Out of these, the sterilization segment is predicted to observe the highest growth rate over the forecast period on account of better removal of contaminants through this method. Further, the sterilization section is further segmented into hydrogen peroxide, ethylene oxide gas sterilization, radiation, steam and others, out of which, radiation held a significant share in the market in 2018. This can be attributed to the higher degree of decontamination and compatibility with a larger number of instruments. Advanced methods of radiation sterilization including electron-beam sterilization and gamma ray sterilization are increasingly being preferred over other sterilization products despite the cost effectiveness of other methods such as autoclave.
By End User
The instrument infection control market is segmented on the basis of end user into hospitals, pharmaceutical & life sciences companies, academic & research institutes, clinics and others, out of which, the hospitals segment holds the largest share in the market and is projected to grow at a significantly high growth rate during the forecast period. The improved facilities at hospitals combined with the presence of large patient population are the leading factors anticipated to be responsible for the market growth. Moreover, the surgical instruments and medical devices required during surgical procedures are cleaned and sterilized each time, which raises the demand for the market in hospitals further.
The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
Market Drivers and Challenges
Growth Indicators
The foremost factor responsible for driving the market growth is the rise in hospital-acquired infections. The medical instruments used at various healthcare settings such as hospitals, surgical centers and ambulatory clinics require sterilization after every use. This is done to protect the patients from exposure to external pathogens. For instance, the usage of infected surgical instruments in dental care result in periodontal diseases which are caused by various microbes. Moreover, the growing cases of disorders, especially among the elderly population, increase the growth of medical and the pharmaceutical industry. The advancements in these industries result in higher efficiency and better performance of modern equipment which further gives rise to the demand for effective sterilization methods for these instruments and products. The innovations in sterilization methods such as use of sterilizers with self-generated steam inside chambers and heat sterilization in place of cold sterilization occur as a result of technological advancements in the industry.
Barriers
The process of heat sterilization can be used only for thermo stable instruments since it requires extremely high heat. Likewise, gas sterilization uses alkylating agents that are potentially carcinogenic and hence might be harmful for the health of patients. In case of radiation sterilization, the radioactive material necessitates proper handling and disposal. The disadvantages of various sterilization methods are anticipated to act as barriers for the growth of the market in the upcoming years. Moreover, the strict government rules and regulations regarding the production and quality of medical devices that are sterilized restricts the entry of new players in the market, which is estimated to hamper the market growth further.
Competitive Landscape
Some of the affluent industry leaders in the global instrument infection control market are 3M, Getinge, Steris, Belimed, Cantel, Matachana, MMM Group and Steelco. Moreover, other key and niche players are working towards the expansion of product portfolio along with investing in high quality R&D to develop highly engineered and innovative technologies for sterilization instruments in order to gain competitive edge in the global instrument infection control market.
